dc.contributor.author | Honauer, I. | |
dc.contributor.author | Klamroth, R. | |
dc.contributor.author | Engl, W. | |
dc.contributor.author | Fernandez, A. | |
dc.contributor.author | Lee, H. -Y. | |
dc.contributor.author | Zulfikar, B. | |
dc.contributor.author | Windyga, J. | |
dc.contributor.author | Collins, P. | |
dc.contributor.author | Escuriola-Ettingshausen, C. | |
dc.contributor.author | Escobar, M. | |
dc.contributor.author | Shapiro, S. | |
dc.contributor.author | Tangada, S. D. | |
dc.date.accessioned | 2021-03-06T11:36:46Z | |
dc.date.available | 2021-03-06T11:36:46Z | |
dc.identifier.citation | Windyga J., Collins P., Escuriola-Ettingshausen C., Escobar M., Shapiro S., Zulfikar B., Tangada S. D. , Engl W., Honauer I., Fernandez A., et al., "RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES", HAEMOPHILIA, cilt.26, ss.25, 2020 | |
dc.identifier.issn | 1351-8216 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_efd66c31-274e-4caf-84e8-cfe46240d0cf | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/157418 | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | İç Hastalıkları | |
dc.subject | Hematoloji | |
dc.subject | Hematology | |
dc.subject | Health Sciences | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | HEMATOLOJİ | |
dc.title | RURIOCTOCOG ALFA PEGOL PK-GUIDED PROPHYLAXIS TARGETING TWO FVIII TROUGH LEVELS IN SEVERE HEMOPHILIA A PATIENTS (PROPEL PHASE 3 STUDY): IMPACT OF PATIENT FVIII HALF-LIFE ON CONSUMPTION AND EFFICACY OUTCOMES | |
dc.type | Makale | |
dc.relation.journal | HAEMOPHILIA | |
dc.contributor.department | İstanbul Üniversitesi , , | |
dc.identifier.volume | 26 | |
dc.identifier.startpage | 25 | |
dc.identifier.endpage | 25 | |
dc.contributor.firstauthorID | 273511 | |